このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Ipca Laboratories バランスシートの健全性
財務の健全性 基準チェック /56
Ipca Laboratoriesの総株主資本は₹77.3B 、総負債は₹13.9Bで、負債比率は18%となります。総資産と総負債はそれぞれ₹111.0Bと₹33.7Bです。 Ipca Laboratoriesの EBIT は₹9.6Bで、利息カバレッジ比率7です。現金および短期投資は₹8.6Bです。
主要情報
18.0%
負債資本比率
₹13.88b
負債
| インタレスト・カバレッジ・レシオ | 7x |
| 現金 | ₹8.55b |
| エクイティ | ₹77.27b |
| 負債合計 | ₹33.74b |
| 総資産 | ₹111.01b |
財務の健全性に関する最新情報
Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly
Jan 09
Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?
Aug 20Ipca Laboratories (NSE:IPCALAB) Has A Pretty Healthy Balance Sheet
Feb 28Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly
Sep 20Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?
Jun 22Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?
Mar 15Recent updates
Ipca Laboratories' (NSE:IPCALAB) Solid Earnings Have Been Accounted For Conservatively
Jun 07Ipca Laboratories Limited (NSE:IPCALAB) Not Lagging Market On Growth Or Pricing
May 24Investors Interested In Ipca Laboratories Limited's (NSE:IPCALAB) Earnings
Feb 07Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly
Jan 09Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?
Aug 20Ipca Laboratories (NSE:IPCALAB) Has A Pretty Healthy Balance Sheet
Feb 28Here's Why Ipca Laboratories (NSE:IPCALAB) Can Manage Its Debt Responsibly
Sep 20Estimating The Intrinsic Value Of Ipca Laboratories Limited (NSE:IPCALAB)
Aug 31Is Ipca Laboratories (NSE:IPCALAB) A Risky Investment?
Jun 22Calculating The Fair Value Of Ipca Laboratories Limited (NSE:IPCALAB)
May 28Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?
Mar 15These 4 Measures Indicate That Ipca Laboratories (NSE:IPCALAB) Is Using Debt Reasonably Well
Sep 20Is Now The Time To Put Ipca Laboratories (NSE:IPCALAB) On Your Watchlist?
Aug 09Does Ipca Laboratories (NSE:IPCALAB) Have A Healthy Balance Sheet?
Jun 08How Does Ipca Laboratories Limited (NSE:IPCALAB) Stand Up To These Simple Dividend Safety Checks?
Mar 26Do Ipca Laboratories's (NSE:IPCALAB) Earnings Warrant Your Attention?
Mar 13Trade Alert: The Compliance Officer Of Ipca Laboratories Limited (NSE:IPCALAB), Harish Kamath, Has Sold Some Shares Recently
Feb 28Ipca Laboratories Limited's (NSE:IPCALAB) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Feb 23Does Ipca Laboratories' (NSE:IPCALAB) CEO Salary Compare Well With Industry Peers?
Feb 11Could The Ipca Laboratories Limited (NSE:IPCALAB) Ownership Structure Tell Us Something Useful?
Jan 30The Ipca Laboratories (NSE:IPCALAB) Share Price Is Up 264% And Shareholders Are Boasting About It
Jan 15Ipca Laboratories (NSE:IPCALAB) Seems To Use Debt Rather Sparingly
Dec 31
Don't Ignore The Fact That This Insider Just Sold Some Shares In Ipca Laboratories Limited (NSE:IPCALAB)
Dec 16The Case For Ipca Laboratories Limited (NSE:IPCALAB): Could It Be A Nice Addition To Your Dividend Portfolio?
Dec 13This Insider Has Just Sold Shares In Ipca Laboratories Limited (NSE:IPCALAB)
Nov 28Is Now The Time To Put Ipca Laboratories (NSE:IPCALAB) On Your Watchlist?
Nov 25Ipca Laboratories Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Nov 10Is Ipca Laboratories Limited's (NSE:IPCALAB) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Nov 08Do Insiders Own Lots Of Shares In Ipca Laboratories Limited (NSE:IPCALAB)?
Oct 24財務状況分析
短期負債: IPCALABの 短期資産 ( ₹55.4B ) が 短期負債 ( ₹23.6B ) を超えています。
長期負債: IPCALABの短期資産 ( ₹55.4B ) が 長期負債 ( ₹10.2B ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: IPCALABの 純負債対資本比率 ( 6.9% ) は 満足できる 水準であると考えられます。
負債の削減: IPCALABの負債対資本比率は、過去 5 年間で14.8%から18%に増加しました。
債務返済能力: IPCALABの負債は 営業キャッシュフロー によって 十分にカバー されています ( 68.1% )。
インタレストカバレッジ: IPCALABの負債に対する 利息支払い は EBIT ( 7 x coverage) によって 十分にカバーされています。